共 121 条
[1]
Bouxsein ML(2006)Bone geometry and skeletal fragility Curr Osteoporos Rep 4 49-56
[2]
Karasik D(2003)The structural and biomechanical basis of the gain and loss of bone strength in women and men Endocrinol Metab Clin North Am 32 25-38
[3]
Seeman E(2003)Invited review: pathogenesis of osteoporosis J Appl Physiol 95 2142-2151
[4]
Seeman E(2003)Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis Endocr Regul 37 227-240
[5]
Stepan JJ(2001)Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis Clin Chem 47 694-702
[6]
Alenfeld F(1988)Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment J Clin Invest 82 1268-1274
[7]
Boivin G(1997)The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis J Bone Miner Res 12 624-631
[8]
Garnero P(1999)Boner turnover and the response to alendronate treatment in postmenopausal osteoporosis Calcif Tissue Int 65 359-364
[9]
Borel O(2004)Determinants of one-year response of lumbar bone mineral density to alendronate treatment in elderly Japanese women with osteoporosis Yonsei Med J 45 676-682
[10]
Delmas PD(2005)Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis Endocr J 52 667-674